Makers Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 5.90 Cr
- Company Age 40 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 34.02 Cr
- Satisfied Charges ₹ 19.97 Cr
- Revenue Growth -17.98%
- Profit Growth -3802.50%
- Ebitda -235.64%
- Net Worth 15.87%
- Total Assets -0.81%
About Makers Laboratories
Makers Laboratories Ltd (MLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 09 July 1984 and has a history of 40 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506919.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 5.90 Cr.
The company currently has active open charges totaling ₹34.02 Cr. The company has closed loans amounting to ₹19.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Makers Laboratories Ltd India are Sandeep Kadam as Cfo, Piyush Ajmera as Company Secretary, and Mr Parikh as Ceo. Raj Verma, Dipti Shah, Nilesh Jain, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24230MH1984PLC033389
- Company No.
033389
- Stock Symbol
BSE : 506919
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Jul 1984
- Date of AGM
06 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Makers Laboratories Ltd offer?
Makers Laboratories Ltd offers a wide range of products and services, including Health Conditions, Heart Care, Kidney Care, Liver Care, Vitamins & Supplements, Multivitamins, Cold & Cough, Healthcare Devices, Thermometers.
Who are the key members and board of directors at Makers Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Kadam  | CFO | 30-Oct-2017 | Current |
| Piyush Ajmera | Company Secretary | 19-Jun-2024 | Current |
| Mr Parikh | CEO | 30-Oct-2017 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Verma | Director | 13-Feb-2019 | Current |
| Dipti Shah | Director | 29-Jan-2018 | Current |
| Nilesh Jain | Whole-Time Director | 13-Feb-2019 | Current |
| Saahil Parikh | Ceo and Whole-Time Director | 11-Aug-2011 | Current |
| Vishal Jain | Director | 04-Nov-2020 | Current |
| Prashant Godha | Director | 08-Apr-1998 | Current |
Financial Performance of Makers Laboratories.
Makers Laboratories Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.98% decrease. The company also saw a substantial fall in profitability, with a 3802.5% decrease in profit. The company's net worth Soared by an impressive increase of 15.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Makers Laboratories?
In 2023, Makers Laboratories had a promoter holding of 61.28% and a public holding of 38.71%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vipra Closures Private LimitedVishal Jain is a mutual person
Numantra Technologies Private LimitedRaj Verma is a mutual person
Ipca FoundationPrashant Godha is a mutual person
Ipca Laboratories LimitedPrashant Godha is a mutual person
Krebs Biochemicals And Industries LimitedRaj Verma is a mutual person
Capricoating Solutions Private LimitedPrashant Godha is a mutual person
Charges (Loans)
₹34.02 Cr
₹19.97 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 20.70 Cr
- State Bank Of India : 11.80 Cr
- The Shamrao Vithal Co-Op. Bank Ltd. : 0.97 Cr
- Allahabad Bank : 0.32 Cr
- Sarawat Co-Operative Bank Ltd. : 0.13 Cr
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2020 | Yes Bank Limited | ₹10.00 Cr | Open |
| 10 Jul 2019 | Yes Bank Limited | ₹10.70 Cr | Open |
| 19 Oct 2000 | The Saraswat Co-Op Bank Ltd. | ₹0.39 M | Open |
| 19 Nov 1999 | Sarawat Co-Operative Bank Ltd. | ₹1.29 M | Open |
| 11 Mar 1998 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹9.70 M | Open |
How Many Employees Work at Makers Laboratories?
Makers Laboratories has a workforce of 147 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Makers Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makers Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
